Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Characterization of Flavimaculatus-Like Phenotype in PRPH2 associated Inherited Retinal Disease
Author Affiliations & Notes
  • Shaden Yassin
    University of California at San Diego Department of Ophthalmology at the Shiley Eye Institute, La Jolla, California, United States
  • Naomi Wagner
    University of California at San Diego Department of Ophthalmology at the Shiley Eye Institute, La Jolla, California, United States
  • Paripoorna Sharma
    University of California at San Diego Department of Ophthalmology at the Shiley Eye Institute, La Jolla, California, United States
  • Evan Walker
    University of California at San Diego Department of Ophthalmology at the Shiley Eye Institute, La Jolla, California, United States
  • Fritz Gerald Paguiligan Kalaw
    University of California at San Diego Department of Ophthalmology at the Shiley Eye Institute, La Jolla, California, United States
  • Thiago DeOliveira
    Oregon Health & Science University Casey Eye Institute, Portland, Oregon, United States
  • Katherine Andersen
    Oregon Health & Science University Casey Eye Institute, Portland, Oregon, United States
  • Molly Marra
    Oregon Health & Science University Casey Eye Institute, Portland, Oregon, United States
  • Lesley Everett
    Oregon Health & Science University Casey Eye Institute, Portland, Oregon, United States
  • Paul Yang
    Oregon Health & Science University Casey Eye Institute, Portland, Oregon, United States
  • Mark E Pennesi
    Retina Foundation of the Southwest, Dallas, Texas, United States
  • Shyamanga Borooah
    University of California at San Diego Department of Ophthalmology at the Shiley Eye Institute, La Jolla, California, United States
  • Footnotes
    Commercial Relationships   Shaden Yassin None; Naomi Wagner None; Paripoorna Sharma None; Evan Walker None; Fritz Gerald Kalaw None; Thiago DeOliveira None; Katherine Andersen None; Molly Marra None; Lesley Everett None; Paul Yang None; Mark Pennesi 4D Molecular Therapetuics, Adverum, Arrowhead Pharmceuticals, AGTC, Aldebaran, Ascidian, Atsena, Astellas, BlueRock - Opsis, Coave, ClarisBio, Dompe, Editas, Edigene, Endogena, FFB, Ingel Therapeutics, J-Cyte, Janssen, Kala Therapeutics, Kiora, Nacuity Pharmaceuticals, Ocugen, Ora, ProQR, Prime Editing, PTC Therapeutics, PYC Therapeutics, Ray Therapeutics, Rejuvitas, Restore Vision, RegenexBio, Sparing Vision, SpliceBio, Spotlight Therapeutics, Thea , Code C (Consultant/Contractor), AGTC, Biogen, Editas, FFB, ProQR, Reneuron, Sanofi, Code S (non-remunerative); Shyamanga Borooah Nixon Vision Award, Foundation Fighting Blindness CD-GT-0918-0746-SE , Code R (Recipient)
  • Footnotes
    Support  Nixon vision award of the foundation fighting blindness,UCSD Center Core Grant for Vision Research P30EY022589
Investigative Ophthalmology & Visual Science June 2024, Vol.65, OD74. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Shaden Yassin, Naomi Wagner, Paripoorna Sharma, Evan Walker, Fritz Gerald Paguiligan Kalaw, Thiago DeOliveira, Katherine Andersen, Molly Marra, Lesley Everett, Paul Yang, Mark E Pennesi, Shyamanga Borooah; Characterization of Flavimaculatus-Like Phenotype in PRPH2 associated Inherited Retinal Disease. Invest. Ophthalmol. Vis. Sci. 2024;65(7):OD74.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Pathogenic variants in PRPH2 have been associated with multiple clinical inherited retinal disease (IRD) phenotypes. Several studies have highlighted marked PRPH2 phenotypic heterogeneity between pathogenic variants at different loci and even at a single locus. There is a lack of data on the characterization of certain PRPH2 endophenotypes. We aim to address this knowledge gap by describing retinal flecks findings in a cohort of PRPH2-associated IRD patients from two IRD referral centers.

Methods : Cases with molecularly confirmed PRPH2 IRD seen at the IRD clinics University of California San Diego, and Oregon Health & Science University were reviewed. Data collected included demographics, disease phenotype, genotype, best corrected visual acuity (BCVA), ultra-widefield fundus autofluorescence (FAF) photos, and spectral domain optical coherence tomography. Staging of the retinal flecks was performed using Fishman staging classification originally used for Stargardt disease and the topographic distribution was investigated using a Boston Grid. The statistical analysis was conducted per subject eye level through Linear Mixed Effects modeling using R statistical software.

Results : In total, 73 patients were reviewed. Of these, 37 patients (74 eyes) had retinal flecks and were included in the final analysis. The mean age was 57.3 (range 53.1, 61.5) years and 24 (65%) patients were female. Fishman stage 2 was the most common stage affecting 33 (44.6%) eyes (Figure 1). PRPH2 c.828+3A>T was the most common pathogenic variant affecting 12 (32.4%) of the subjects.
Fishman stage 4 demonstrated the worst BCVA (1.046 LogMAR (95% CI, 0.783, 1.309)) compared to other stages (p<0.001) (Figure 2). Central subfield thickness was significantly thicker in Fishman stage 4 eyes (300.7 µm (95% CI, 264.6, 335.9) compared to other stages (p<0.001) (Figure 2).
No significant association was found between different Fishman stages and the topographic distribution of the retinal flecks using Boston Grid.

Conclusions : The Flavimaculatus Like phenotype appears to be a common form of PRPH2 associated IRD that is not restricted to a certain topographic distribution and is associated with structural changes to the central macula.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

Figure 1: Distribution of different Fishman Classification stages in the entire cohort.

Figure 1: Distribution of different Fishman Classification stages in the entire cohort.

 

Figure 2: Correlation between different Fishman stages and best corrected visual acuity and central subfield thickness

Figure 2: Correlation between different Fishman stages and best corrected visual acuity and central subfield thickness

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×